These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10340289)

  • 1. Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research.
    Dursun SM; Kutcher S
    Med Hypotheses; 1999 Feb; 52(2):101-9. PubMed ID: 10340289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of smoking and nicotine in neuropsychiatric disorders: evidence for therapeutic role of nicotinic acetylcholine receptors].
    Miyata H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):149-58. PubMed ID: 18800618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuropharmacology of smoking: basic research opens new therapeutic possibilities].
    Svensson TH; Grenhoff J
    Lakartidningen; 1991 May; 88(22):2066-71. PubMed ID: 2051876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The smoking gun: many conditions associated with tobacco exposure may be attributable to paradoxical compensatory autonomic responses to nicotine.
    Yun AJ; Bazar KA; Lee PY; Gerber A; Daniel SM
    Med Hypotheses; 2005; 64(6):1073-9. PubMed ID: 15823687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobiology of nicotine addiction: implications for smoking cessation treatment.
    Benowitz NL
    Am J Med; 2008 Apr; 121(4 Suppl 1):S3-10. PubMed ID: 18342164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report.
    Ziedonis D; Hitsman B; Beckham JC; Zvolensky M; Adler LE; Audrain-McGovern J; Breslau N; Brown RA; George TP; Williams J; Calhoun PS; Riley WT
    Nicotine Tob Res; 2008 Dec; 10(12):1691-715. PubMed ID: 19023823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine, brain nicotinic receptors, and neuropsychiatric disorders.
    Mihailescu S; Drucker-Colín R
    Arch Med Res; 2000; 31(2):131-44. PubMed ID: 10880717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological aspects of the link between smoking and depression.
    Quattrocki E; Baird A; Yurgelun-Todd D
    Harv Rev Psychiatry; 2000 Sep; 8(3):99-110. PubMed ID: 10973935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nicotine acetylcholine receptors and neuropsychiatric disorders].
    Vázquez-Palacios G; Bonilla-Jaime H
    Rev Neurol; 2004 Dec 16-31; 39(12):1146-60. PubMed ID: 15625635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine: abused substance and therapeutic agent.
    Le Houezec J
    J Psychiatry Neurosci; 1998 Mar; 23(2):95-108. PubMed ID: 9549250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases.
    Egleton RD; Brown KC; Dasgupta P
    Pharmacol Ther; 2009 Feb; 121(2):205-23. PubMed ID: 19063919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine and brain disorders.
    Mihailescu S; Drucker-Colín R
    Acta Pharmacol Sin; 2000 Feb; 21(2):97-104. PubMed ID: 11263271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders.
    Bacher I; Wu B; Shytle DR; George TP
    Expert Opin Pharmacother; 2009 Nov; 10(16):2709-21. PubMed ID: 19874251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and synaptic mechanisms of nicotine addiction.
    Mansvelder HD; McGehee DS
    J Neurobiol; 2002 Dec; 53(4):606-17. PubMed ID: 12436424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine dependence and psychiatric disorders.
    Salín-Pascual RJ; Alcocer-Castillejos NV; Alejo-Galarza G
    Rev Invest Clin; 2003; 55(6):677-93. PubMed ID: 15011738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous nicotine normalises sensory gating in schizophrenia; therapeutic implications.
    Conway JL
    Med Hypotheses; 2009 Aug; 73(2):259-62. PubMed ID: 19328631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of nicotine and attention allocation on physiological and self-report measures of induced anxiety in PTSD: a double-blind placebo-controlled trial.
    Buckley TC; Holohan DR; Mozley SL; Walsh K; Kassel J
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):154-64. PubMed ID: 17469939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinic acetylcholine receptor system and neuropsychiatric disorders.
    Singh A; Potter A; Newhouse P
    IDrugs; 2004 Dec; 7(12):1096-103. PubMed ID: 15599803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine psychopharmacology: policy and regulatory.
    Henningfield JE; Zeller M
    Handb Exp Pharmacol; 2009; (192):511-34. PubMed ID: 19184661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine: from molecular mechanisms to behaviour.
    Wonnacott S; Sidhpura N; Balfour DJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):53-9. PubMed ID: 15661626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.